上海医药 (601607.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(上海医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2022年一季报2021年年报2021年三季报2021年中报2021年一季报2020年年报2020年三季报2020年中报2020年一季报
主要指标:
 营业收入(元) 56,898,217,119.51215,824,259,035.31160,972,711,401.28105,237,468,881.9751,599,987,610.03191,909,156,160.88140,322,522,230.4587,165,105,135.3940,448,399,399.41
 营业利润(元) 1,995,123,812.468,205,486,305.156,801,302,083.715,230,127,338.932,991,828,652.087,184,388,142.565,477,603,822.863,633,508,880.431,592,917,113.56
 利润总额(元) 1,986,577,269.948,143,814,892.366,796,578,442.145,217,563,188.522,997,112,504.447,175,482,563.635,475,276,362.463,603,876,705.731,566,664,318.81
 净利润(元) 1,532,331,542.586,274,569,444.125,363,949,402.564,164,790,611.862,377,986,058.215,605,264,037.244,357,812,202.172,881,162,958.091,227,761,734.37
 归属于母公司股东的净利润(元) 1,251,018,657.925,093,467,260.974,484,231,938.153,567,759,976.702,120,145,073.354,496,216,958.553,601,996,155.562,442,842,195.881,038,075,670.94
盈利能力:
 销售毛利率(%) 12.8813.2313.4913.7113.7114.3014.3715.0415.46
 销售净利率(%) 2.692.913.333.964.612.923.113.313.04
 净资产收益率(%) 2.2310.769.647.874.71----
 总资产报酬率ROA(%) 1.396.014.953.782.23----
 投入资本回报率ROIC(%) 1.326.185.354.332.565.594.513.051.27
营运能力:
 存货周转率(次) 2.017.325.833.781.79----
 应收账款周转率(次) 0.963.892.801.951.02----
 总资产周转率(次) 0.341.381.030.690.35----
偿债能力:
 资产负债率(%) 59.1463.8664.4163.8463.6463.3164.1065.0063.63
 股东权益比率(%) 35.4530.2029.8030.1230.4030.4029.7929.0230.16
 已获利息倍数(倍) 6.547.548.3110.0110.486.796.596.375.41
 流动比率 1.421.271.271.231.221.221.331.291.34
 速动比率 1.110.940.960.950.900.921.000.970.95
发展能力:
 营业收入增长率(%) 10.2712.4614.7220.7327.572.86-0.21-5.84-12.08
 营业利润增长率(%) -33.3114.2124.1743.9487.8215.6211.003.74-4.07
 税后利润增长率(%) -40.9913.2824.4946.05104.2410.175.976.84-7.84
 净资产增长率(%) 36.048.839.6811.1711.308.878.407.076.26
 总资产增长率(%) 16.669.559.677.1110.448.879.7710.455.07

前瞻产业研究院